(Q52894312)

http://europepmc.org/abstract/PMC/6388939

2 July 2019

title

Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease. (English)

1 reference

http://europepmc.org/abstract/PMC/6388939

2 July 2019

main subject

left ventricular hypertrophy

1 reference

inferred from title

author

Maren Leifheit-Nestler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Wolfgang H. Ziegler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

Dagmar-Christiane Fischer

9 June 2020

12

object named as

Dagmar-Christiane Fischer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Robert Große Siemer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kathrin Flasbart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Beatrice Richter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Felix Kirchhoff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Michael Klintschar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jan U Becker

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Andreas Erbersdobler

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Christoph Aufricht

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Tomas Seeman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Christian Faul

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Dieter Haffner

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

17 December 2015

1 reference

http://europepmc.org/abstract/PMC/6388939

2 July 2019

published in

Nephrology Dialysis Transplantation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

1088-1099

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Evolving importance of kidney disease: from subspecialty to global health burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Cardiovascular disease in children with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

FGF23 induces left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Masked hypertension associates with left ventricular hypertrophy in children with CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Multidirectional myocardial systolic function in hemodialysis patients with preserved left ventricular ejection fraction and different left ventricular geometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Disordered FGF23 and mineral metabolism in children with CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Klotho and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Update on fibroblast growth factor 23 in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Fibroblast growth factor 23 in patients undergoing peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Regulation of fibroblast growth factor-23 signaling by klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Klotho converts canonical FGF receptor into a specific receptor for FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Growth hormone and Klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Klotho and phosphate are modulators of pathologic uremic cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Fibroblast growth factor 23 and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Circulating αKlotho influences phosphate handling by controlling FGF23 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

The kidney is the principal organ mediating klotho effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

The impact of nephrectomy and renal transplantation on serum levels of soluble Klotho protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

αKlotho: FGF23 coreceptor and FGF23-regulating hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Parsing good versus bad signaling pathways in the heart: role of calcineurin-nuclear factor of activated T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Molecular basis of physiological heart growth: fundamental concepts and new players

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Heart-specific deletion of CnB1 reveals multiple mechanisms whereby calcineurin regulates cardiac growth and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

FGF23 and mineral metabolism in the early post-renal transplantation period

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV421

Cardiovascular mortality in children and young adults with end-stage kidney disease

21 January 2018

1 reference

12 December 2020

Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism

1 reference

12 December 2020

Signaling to gene expression: calcium, calcineurin and NFAT

1 reference

12 December 2020

Cardioprotective effect of calcineurin inhibition in an animal model of renal disease

1 reference

12 December 2020

Clinical significance of FGF-23 measurement in dialysis patients

1 reference

12 December 2020

Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients

1 reference

12 December 2020

Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDT/GFV421

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

PubMed publication ID

26681731

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681731%20AND%20SRC:MED&resulttype=core&format=json